MedPath

Covalon Technologies Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:2
Not Applicable:2

Drug Approvals

4

CANADA:2

Drug Approvals

COVALONGUARD SPRAY

Approval Date
Jun 26, 2020
CANADA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 1
2 (50.0%)

HRIPT for Collagen Dressing

Not Applicable
Completed
Conditions
Skin Sensitisation
First Posted Date
2024-02-28
Last Posted Date
2025-03-12
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
86
Registration Number
NCT06283173
Locations
🇺🇸

ALS Beauty and Personal Care, Torrance, California, United States

SPT for Sensitization of Collagen Dressing

Not Applicable
Recruiting
Conditions
Allergy Skin
Allergic Skin Reaction
First Posted Date
2024-02-22
Last Posted Date
2024-02-23
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
30
Registration Number
NCT06271993
Locations
🇺🇸

ALS Beauty and Personal Care, Torrance, California, United States

Human Repeat Insult Patch Test of Wound Dressings

Phase 1
Completed
Conditions
Skin Sensitization
First Posted Date
2011-06-07
Last Posted Date
2025-03-25
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
216
Registration Number
NCT01368146
Locations
🇺🇸

Hill Top Research, Saint Petersburg, Florida, United States

Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth

Phase 1
Completed
Conditions
Skin Flora Infection
First Posted Date
2011-06-07
Last Posted Date
2015-04-16
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
37
Registration Number
NCT01368120
Locations
🇺🇸

Hill Top Research, Miamiville, Ohio, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.